These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39009083)

  • 1. Two-pronged anti-cancer nanovaccines enpowered by exogenous/endogenous tumor-associated antigens.
    Yin M; Liu Z; Zhou Y; Li W; Yan J; Cao D; Yin L
    J Control Release; 2024 Sep; 373():358-369. PubMed ID: 39009083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetradecanol-wrapped, CpG-loaded porous Prussian blue nanoimmunomodulator for photothermal-responsive in situ anti-tumor vaccine-like immunotherapy.
    Yin C; Xing Y; Zhao P; Yin Y; Yao H; Xue J; Gu W
    Biomater Adv; 2024 Nov; 164():213996. PubMed ID: 39146604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Associated Myeloid Cells Selective Delivery of a Therapeutic Tumor Nano-Vaccine for Overcoming Immune Barriers for Effective and Long-Term Cancer Immunotherapy.
    Wang C; Zhao J; Duan Y; Lin L; Zhang Q; Zheng H; Shan W; Wang X; Ren L
    Adv Healthc Mater; 2024 Oct; 13(26):e2401416. PubMed ID: 38848734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy.
    Liu Z; Liu B; Feng Y; Zhao L; Wang Q; He H; Yin T; Zhang Y; Yang L; Gou J; Tang X
    ACS Nano; 2024 Jun; 18(24):15557-15575. PubMed ID: 38837909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy and Prevention of Cancer by Nanovaccines Loaded with Whole-Cell Components of Tumor Tissues or Cells.
    Ma L; Diao L; Peng Z; Jia Y; Xie H; Li B; Ma J; Zhang M; Cheng L; Ding D; Zhang X; Chen H; Mo F; Jiang H; Xu G; Meng F; Zhong Z; Liu M
    Adv Mater; 2021 Oct; 33(43):e2104849. PubMed ID: 34536044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy.
    Pan Y; Wu X; Liu L; Zhao C; Zhang J; Yang S; Pan P; Huang Q; Zhao XZ; Tian R; Rao L
    Adv Healthc Mater; 2024 May; 13(13):e2400068. PubMed ID: 38320299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen Self-Presented Personalized Nanovaccines Boost the Immunotherapy of Highly Invasive and Metastatic Tumors.
    Wang T; Han M; Han Y; Jiang Z; Zheng Q; Zhang H; Li Z
    ACS Nano; 2024 Feb; 18(8):6333-6347. PubMed ID: 38349234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acidity-responsive polyphenol-coordinated nanovaccines for improving tumor immunotherapy
    Qiu H; Wang S; Huang R; Liu X; Li L; Liu Z; Wang A; Ji S; Liang H; Jiang BP; Shen XC
    Biomater Sci; 2024 Jun; 12(12):3175-3192. PubMed ID: 38742916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Dose Soft X-Ray Remotely Triggered Lanthanide Nanovaccine for Deep Tissue CO Gas Release and Activation of Systemic Anti-Tumor Immunoresponse.
    Li Y; Jiang M; Deng Z; Zeng S; Hao J
    Adv Sci (Weinh); 2021 Jun; 8(12):e2004391. PubMed ID: 34165903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species/glutathione dual sensitive nanoparticles with encapsulation of miR155 and curcumin for synergized cancer immunotherapy.
    Li K; Wang J; Xie Y; Lu Z; Sun W; Wang K; Liang J; Chen X
    J Nanobiotechnology; 2024 Jul; 22(1):400. PubMed ID: 38972995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy.
    Zheng J; Wang M; Pang L; Wang S; Kong Y; Zhu X; Zhou X; Wang X; Chen C; Ning H; Zhao W; Zhai W; Qi Y; Wu Y; Gao Y
    J Control Release; 2024 Sep; 373():568-582. PubMed ID: 39067792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine.
    Kim H; Khanna V; Kucaba TA; Zhang W; Ferguson DM; Griffith TS; Panyam J
    Mol Pharm; 2019 Mar; 16(3):1200-1210. PubMed ID: 30620878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor associated antigens combined with carbon dots for inducing durable antitumor immunity.
    Liu H; Zhang T; Zheng M; Xie Z
    J Colloid Interface Sci; 2024 Nov; 673():594-606. PubMed ID: 38897061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy.
    Li T; Chen G; Lin L; Li B; Wang X; Chen Y; Huang W; Cai M; Xiao Z; Shuai X; Zhu K
    Biomaterials; 2024 Sep; 309():122626. PubMed ID: 38795524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
    Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
    BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA-
    Cao Q; Zhou R; Guo S; Meng K; Yang X; Liu M; Ma B; Su C; Duan X
    Int J Nanomedicine; 2024; 19():9437-9458. PubMed ID: 39290859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy.
    Jahanafrooz Z; Oroojalian F; Mokhtarzadeh A; Rahdar A; Díez-Pascual AM
    Drug Dev Res; 2024 Aug; 85(5):e22244. PubMed ID: 39138855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of anti-miRNA21 sensitizes PD-L1
    Kim EH; Choi J; Jang H; Kim Y; Lee JW; Ryu Y; Choi J; Choi Y; Chi SG; Kwon IC; Yang Y; Kim SH
    Theranostics; 2024; 14(10):3777-3792. PubMed ID: 38994018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.